Last $13.67 USD
Change Today +0.33 / 2.47%
Volume 439.9K
DANOY On Other Exchanges
Symbol
Exchange
OTC US
EN Paris
SIX Swiss Ex
OTC US
BrsaItaliana
Berlin
Mexico
As of 5:20 PM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

danone-spons adr (DANOY) Snapshot

Open
$13.58
Previous Close
$13.34
Day High
$13.67
Day Low
$13.52
52 Week High
07/22/14 - $15.84
52 Week Low
10/17/14 - $12.32
Market Cap
44.0B
Average Volume 10 Days
873.8K
EPS TTM
--
Shares Outstanding
3.2B
EX-Date
05/2/14
P/E TM
--
Dividend
$0.39
Dividend Yield
2.90%
Current Stock Chart for DANONE-SPONS ADR (DANOY)

Related News

No related news articles were found.

danone-spons adr (DANOY) Details

Danone produces and distributes food and beverage products. The company’s Fresh Dairy Products division provides yogurts, fermented fresh dairy products, and specialized dairy products under the Activia, Danonino, Fruchtswerge, Danoninho, Petit Gervais, Danimals, Serenito, Milkuat, Tëma, Actimel, Danacol, Densia, Oikos, Danio, Danette, Fantasia, Danissimo, YoCrunch, Vitalinea, Taillefine, and Ser brands. Its Waters division offers packaged natural, flavored, and vitamin-enriched water under Evian, Volvic, Bonafont, Mizone, Aqua, Fontvella, Lanjarón, Villavicencio, Villa del Sur, and Zywiec Zdroj brands. The company’s Early Life Nutrition division produces and distributes specialized food for babies and young children to complement breast-feeding, as well as solid foods for babies under Aptamil, Nutrilon, Almiron, Gallia, Bebelac, Cow&Gate, Blédina, and Malyutka brands. Its Medical Nutrition division provides specialized food for people receiving medical treatment, babies afflicted with certain illnesses, and frail elderly people. Its products include liquid oral nutritional supplements; hypoallergenic products; oral and feeding tube food products for the dietary treatment of infants and children who are incapable of feeding themselves or suffer from illness related malnutrition; and nutritional products for special medical needs. This division markets its products primarily under the Nutricia brand. The company serves individual consumers, retail chains, and traditional market outlets, as well as specialized distribution channels of hospitals, clinics, and pharmacies. It has operations in Russia, France, the United States, China, Indonesia, Spain, Mexico, Argentina, the United Kingdom, and Brazil. Danone has a strategic agreement with Starbucks to create and develop a line of Dannon-branded fresh dairy products. The company was formerly known as Groupe Danone and changed its name to Danone in April 2009. Danone was founded in 1899 and is based in Paris, France.

104,642 Employees
Last Reported Date: 03/24/14
Founded in 1899

danone-spons adr (DANOY) Top Compensated Officers

Vice Chairman, Chief Executive Officer and Me...
Total Annual Compensation: €1.4M
Compensation as of Fiscal Year 2013.

danone-spons adr (DANOY) Key Developments

Johnson & Johnson Reportedly To Buy Jagdale Healthcare

Johnson & Johnson (NYSE:JNJ) has reportedly emerged as a front-runner to acquire Jagdale Healthcare in a deal estimated at INR 700 crore. Danone (ENXTPA:BN) and Abbott Laboratories (NYSE:ABT) are among the other bidders who are participating in the process managed by investment bank MAPE Advisory.

Fresenius, PE Firms Reportedly Eye Danone's Medical Nutrition Unit

Fresenius SE & Co KGaA (DB:FRE) and private equity houses PAI Partners and Permira Advisers Ltd. are reportedly weighing bids for the medical nutrition unit of Danone (ENXTPA:BN), sources familiar with the situation told Reuters. Fresenius sought to take over the division earlier in 2014 but withdraw from the deal as it considered the price asked to be too high, sources told Reuters. Any agreement is still months away as the transaction is considered a complex one, the news agency noted. PAI is ready to strike any deal for the division along with co-investors, one of the sources added. All companies mentioned declined to comment when contacted by Reuters.

Danone Denies To Conduct Its Strategic Review Of Assets

Danone (ENXTPA:BN) is not not conducting a strategic review of assets. Reuters reported that Danone will acquire Mead Johnson Nutrition Company (NYSE:MJN). Laurent Sacchi, Secretary of Danone said the acquisition of Mead Johnson was absolutely not discussed. "No decision has been made on what the priorities are in the group's external growth programme at that board meeting nor in previous ones and there is no strategic review under way," Sacchi said. Reuters reported in February 2014 said Danone was looking to sell its medical nutrition business, worth between €4 billion and €7 billion. Danone on Sunday declined comment on speculation it might sell its medical nutrition business.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DANOY:US $13.67 USD +0.33

DANOY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Associated British Foods PLC 2,754 GBp -7.00
Baxter International Inc $70.14 USD +0.08
Fresenius SE & Co KGaA €40.99 EUR +0.234
Kraft Foods Group Inc $56.35 USD +0.19
Mondelez International Inc $35.26 USD +0.105
View Industry Companies
 

Industry Analysis

DANOY

Industry Average

Valuation DANOY Industry Range
Price/Earnings 26.9x
Price/Sales 1.4x
Price/Book 2.6x
Price/Cash Flow 29.5x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DANONE-SPONS ADR, please visit www.danone.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.